Alpha Cognition to present ZUNVEYL data from BEACON study at NEI Fall Congress

Alpha Cognition will present new clinical and real-world findings on its Alzheimer’s drug ZUNVEYL at the ASCP Annual Meeting (Oct. 29—Nov. 1, 2026) and the NEI Fall Congress (Nov. 5—8, 2026). Analyses indicate ZUNVEYL use in long-term care settings was associated with favorable cognitive, functional, behavioral, and sleep outcomes.